In the present study, we found that FGF21D2D3 improved hyperlipidemia and directly bound to FGFR1 to activate AMPK, thereby reducing oxidative stress and ameliorating DCM in T2D. This evidence concerns the gene FGFR1 and familial dilated cardiomyopathy.